Hormone used to titrate antithyroid meds for Grave’s
Free T4
Grave’s disease antibody
Anti TSH receptor
Acts on TSHr in pituitary gland –> over-activation of thyroid to produce T3 and T4
Most common benign thyroid nodule
Follicular adenoma
Most common neoplasm of thyroid (benign and malignant combined)
Follicular adenoma
Most common malignant cancer of the thyroid
Papillary carcinoma
DeQuervain thyroiditis
AKA subacute granulomatous thyroiditis
Benign
Follows infection
Presents as painful nodule
Doppler ultrasound finding of benign nodular hyperplasia
Ring of fire
Follicular adenoma of thyroid characteristics
Red light on colour dopplery U/S
Confined in capusle
Different growth pattern from surrounding parenchyma
Most sensitive means of differentiating primary from secondary causes of hyperaldosteronism
Aldosterone-to-renin-ratio (ARR) = ratio of plasma aldo to plasma renin activity
-Measures the rate of production of angiotensin I from endogenous angiotensinogen via renin
-As aldo secretion rises, ARR should fall b/c of Na retention
(RAS decreases when BP high)
Renin function
Angiotensinogen to Angiotensin I
ACE function
Angiotensin I to Angiotensin II
Aldosterone is produced from
Adrenal cortex
Signalled by Ang II
Primary aldosteronism
Conn’s Syndrome
Increased production of aldosterone from adrenal gland –> decreased renin
Renin levels may fall well before plasma aldo is increased
Triad of:
HTN
Hypokalemia
Metabolic alkalosis
Secondary hyperaldosteronism
Decreased renal blood flow (ie. due to obstruction, edematous d/o such as CHF/nephrotic syndrome/cirrhosis, renal vasoconstriction)
RAS stimulated –> aldo hypersecreted
Aldo and renin HIGH
Hashimoto’s antibody
Anti-TPO
Timeframe to recheck TSH
Wait >6wks to recheck TSH after dose change
Regular monitoring is 2-3mo then annually once stable
Hyperthyroid tx
Methimazole (high rate of relapse)
I-131
Starting insulin dose
0.3-0.5 U/kg
Rapid acting insulins (bolus dosing)
Insulin aspart (NovoRapid) Insulin lispro (Humalog)
Short-acting insulins (bolus dosing)
Humulin-R
Novolin-ge Toronto
Intermediate acting insulin (basal dosing)
Humulin-N
Novolin-ge NPH
Long-acting insulin (basal dosing)
Insulin detemir (Levemir) Insulin glargine (Lantus)
Carcinoid syndrome
Flushing (histamine, bradykinin), secretory diarrhea (serotonin), abdo pain, tricuspid regurg, skin color changes, wheezing
Result from carcinoid tumour (slow growing neuroendocrine tumours)
Usually asymptomatic
Once carcinoid symptoms occur then metastasis to LIVER likely has already occurred
Biochemical test to confirm carcinoid syndrome
5-hydroxyindoleacetic acid (5-HIAA) measured in 24h urine sample
Serotonin released by carcinoid tumours –> metabolized by monoamine oxidases in liver, lungs and brain –> 5-HIAA
+ imaging
+ hepatic panel if liver met